At meeting held on 12 May 2021
The Board of Sun Pharma Advanced Research Company at its meeting held on 12 May 2021 has approved to issue 6,74,70,203 convertible warrants at price of Rs 178 per warrant aggregating up to Rs 1200.96 crore to Dilip Shanghvi, promoter of the company and to certain other non-promoter group persons. Upon issue of Warrants in accordance herewith, an amount equivalent to 25% (twenty five per cent) of the total issue size shall be called upfront from the proposed allottees.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
